Randomized, double-blind, placebo-matched, multicenter trial of abacavir/lamivudine or tenofovir/ emtricitabine with lopinavir/ritonavir for initial HIV treatment
SMITH, Kimberly Y, PATEL, Parul, WANNAMAKER, Paul, SHAEFER, Mark S, FINE, Derek, BELLOS, Nicholaos, SLOAN, Louis, LACKEY, Philip, KUMAR, Princy N, SUTHERLAND-PHILLIPS, Denise H, VAVRO, Cindy, LINDA YAU
Published in AIDS (London) (31.07.2009)
Published in AIDS (London) (31.07.2009)
Get full text
Journal Article
Short-term safety and tolerability of a once-daily fixed-dose abacavir-lamivudine combination versus twice-daily dosing of abacavir and lamivudine as separate components: findings from the ALOHA study
Cohen, Calvin J, Kubota, Marshall, Brachman, Philip S, Harley, William B, Schneider, Stefan, Williams, Vanessa C, Sutherland-Phillips, Denise H, Lim, Michael L, Balu, Rukmini B, Shaefer, Mark S
Published in Pharmacotherapy (01.03.2008)
Published in Pharmacotherapy (01.03.2008)
Get more information
Journal Article
First large, multicenter, open-label study utilizing HLA-B5701 screening for abacavir hypersensitivity in North America
YOUNG, Benjamin, SQUIRES, Kathleen, PATEL, Parul, DEJESUS, Edwin, BELLOS, Nicholaos, BERGER, Daniel, SUTHERLAND-PHILLIPS, Denise H, QIMING LIAO, SHAEFER, Mark, WANNAMAKER, Paul
Published in AIDS (London) (20.08.2008)
Published in AIDS (London) (20.08.2008)
Get full text
Journal Article
High Sensitivity of Human Leukocyte Antigen-B5701 as a Marker for Immunologically Confirmed Abacavir Hypersensitivity in White and Black Patients
Saag, Michael, Balu, Rukmini, Phillips, Elizabeth, Brachman, Philip, Martorell, Claudia, Burman, William, Stancil, Britt, Mosteller, Michael, Brothers, Cindy, Wannamaker, Paul, Hughes, Arlene, Sutherland-Phillips, Denise, Mallal, Simon, Shaefer, Mark
Published in Clinical infectious diseases (01.04.2008)
Published in Clinical infectious diseases (01.04.2008)
Get full text
Journal Article
Safety and efficacy of a 36-week induction regimen of abacavir/lamivudine and ritonavir-boosted atazanavir in HIV-infected patients
Squires, Kathleen E, Young, Benjamin, DeJesus, Edwin, Bellos, Nicholas, Murphy, Daniel, Sutherland-Phillips, Denise H, Zhao, Henry H, Patel, Lisa G, Ross, Lisa L, Wannamaker, Paul G, Shaefer, Mark S
Published in HIV clinical trials (01.03.2010)
Published in HIV clinical trials (01.03.2010)
Get more information
Journal Article
Improvements in Patient-Reported Outcomes After 12 Months of Maintenance Therapy With Cabotegravir + Rilpivirine Long-Acting Compared With Bictegravir/Emtricitabine/Tenofovir Alafenamide in the Phase 3b SOLAR Study
Mussini, Cristina, Cazanave, Charles, Adachi, Eisuke, Eu, Beng, Alonso, Marta Montero, Crofoot, Gordon, Chounta, Vasiliki, Kolobova, Irina, Sutton, Kenneth, Sutherland-Phillips, Denise, Urbaityte, Rimgaile, Ehmann, Alice, Scherzer, Jenny, de Los Rios, Patricia, D'Amico, Ronald, Spreen, William, van Wyk, Jean
Published in AIDS and behavior (08.10.2024)
Published in AIDS and behavior (08.10.2024)
Get full text
Journal Article
Factors Associated with Health Care Providers' Preference for Forgoing an Oral Lead-In Phase When Initiating Long-Acting Injectable Cabotegravir and Rilpivirine in the SOLAR Clinical Trial
Karver, Tahilin Sanchez, Pascual-Bernaldez, Miguel, Berni, Alessandro, Hnoosh, Ahmed, Castagna, Antonella, Messiaen, Peter, Puerto, Maria Jose Galindo, Bloch, Mark, Adachi, Eisuke, Sinclair, Gary, Felizarta, Franco, Angel, Jonathan B, Sutton, Kenneth, Sutherland-Phillips, Denise, D'Amico, Ronald, Kerrigan, Deanna
Published in AIDS patient care and STDs (01.01.2023)
Published in AIDS patient care and STDs (01.01.2023)
Get more information
Journal Article
The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 weeks: a randomised non-inferiority trial
Eron, Joseph, Yeni, Patrick, Gathe, Joseph, Estrada, Vicente, DeJesus, Edwin, Staszewski, Schlomo, Lackey, Philip, Katlama, Christine, Young, Benjamin, Yau, Linda, Sutherland-Phillips, Denise, Wannamaker, Paul, Vavro, Cindy, Patel, Lisa, Yeo, Jane, Shaefer, Mark
Published in The Lancet (British edition) (05.08.2006)
Published in The Lancet (British edition) (05.08.2006)
Get full text
Journal Article
1550. Engaging Black Women on Cabotegravir LA for PrEP by Optimizing Novel Implementation Strategies (EBONI) Study: Provider Perceptions of Appropriateness of Cabotegravir LA for PrEP for Cis-and-Trans Black Women
Richmond, Teriya, Dunn, Michael, Bernard, Marye, Urbaityte, Rimgaile, Sutton, Kenneth, Sutherland-Phillips, Denise, Dyson, Alftan, Merrill, Deanna, Chang, Samantha, Mack, Nicole, Haley, Amber, Brown, Kimberley, Evans, Tammeka
Published in Open forum infectious diseases (27.11.2023)
Published in Open forum infectious diseases (27.11.2023)
Get full text
Journal Article
Efficacy, safety, and tolerability of switching to long-acting cabotegravir plus rilpivirine versus continuing fixed-dose bictegravir, emtricitabine, and tenofovir alafenamide in virologically suppressed adults with HIV, 12-month results (SOLAR): a randomised, open-label, phase 3b, non-inferiority trial
Ramgopal, Moti N, Castagna, Antonella, Cazanave, Charles, Diaz-Brito, Vicens, Dretler, Robin, Oka, Shinichi, Osiyemi, Olayemi, Walmsley, Sharon, Sims, James, Di Perri, Giovanni, Sutton, Kenneth, Sutherland-Phillips, Denise, Berni, Alessandro, Latham, Christine L, Zhang, Feifan, D'Amico, Ronald, Pascual Bernáldez, Miguel, Van Solingen-Ristea, Rodica, Van Eygen, Veerle, Patel, Parul, Chounta, Vasiliki, Spreen, William R, Garges, Harmony P, Smith, Kimberly, van Wyk, Jean
Published in The lancet HIV (01.09.2023)
Published in The lancet HIV (01.09.2023)
Get more information
Journal Article
1587. SOLAR 12-Month North American Results: Randomized Switch Trial of CAB+RPV LA vs. Oral BIC/FTC/TAF
McKellar, Mehri, Teichner, Paula, Bettacchi, Christopher, Angel, Jonathan, Gordon, Lori A, Sutton, Kenneth, Sutherland-Phillips, Denise, Talarico, Christine L, Urbaityte, Rimgaile, Solingen-Ristea, Rodica Van, Baugh, Bryan, D’Amico, Ronald, van Wyk, Jean A
Published in Open forum infectious diseases (27.11.2023)
Published in Open forum infectious diseases (27.11.2023)
Get full text
Journal Article